Attana AB (publ) (NGM:ATANA)
0.0090
-0.0010 (-10.00%)
At close: Nov 24, 2025
Attana AB Company Description
Attana AB (publ) provides analytical instruments and services for validating, selecting, and optimizing drug candidates primarily in Sweden.
The company offers contract research services; in vitro diagnostic tools; analytical instruments; and Attana virus analytics.
It serves pharmaceutical and biotechnology companies, and academic institutions. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden.
Attana AB (publ)
| Country | Sweden |
| Founded | 2002 |
| Industry | Commercial Physical and Biological Research |
| Employees | 6 |
| CEO | Anna Hellergård |
Contact Details
Address: Engelbrekts Väg 6 Sollentuna, 191 62 Sweden | |
| Phone | 46 8 41 02 00 00 |
| Website | attana.com |
Stock Details
| Ticker Symbol | ATANA |
| Exchange | Nordic Growth Market |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Anna Hellergård | Chief Executive Officer |
| Cornelia Ekstrom | Chief Financial Officer |